跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-LEVETIRACETAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-LEVETIRACETAM
Authorized
STANDARD
RIVA-LEVETIRACETAM
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
51db5f8cbce9a95c
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
51db5f8cbce9a95c
Drug Approval Canada Name
RIVA-LEVETIRACETAM
Product Name
RIVA-LEVETIRACETAM
Status
Dormant
Status Date
2024-01-02
Original Market Date
2019-04-12
Din
02482282
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX14 LEVETIRACETAM
Atc Name
n 03 ax 14
Aig Number
0148843002
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
LEVETIRACETAM
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
51db5f8cbce9a95c
Type
Standard
Back to Health Canada Approvals